Caitlin Clark may be an all-star on the basketball court, but she couldn’t beat Eli Manning when it came to a game of Pop-A-Shot. On the latest episode of The Eli Manning Show, the former NFL ...

Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now ...

Eli Manning’s still got it — even off the football field. The legendary Giants quarterback, 44, faced off against WNBA star Caitlin Clark in a recent round of Pop-A-Shot on “The Eli Manning ...

Nebraska Gov. Jim Pillen's opening remarks at Boys Town in 2024 In September 2023, the Rev. Steven Boes retired as executive director and president of Boys Town, ending his tenure as the fourth ...

Eli Manning may not be done as a Giant just yet. The two-time Super Bowl MVP, who missed out on his first try for the Pro Football Hall of Fame earlier this month, said Friday he would have ...

Eli Lilly said Tuesday that it will offer more doses of its obesity drug Zepbound in vials and lower the prices of the doses it already sells, as the pharma giant seeks to draw patients away from ...

Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...

For years, Eli Lilly has been generating solid growth numbers -- but lately, they've been accelerating rapidly. The company is coming off a solid quarter where its revenue rose by 45% for the last ...

Former Giants quarterback Eli Manning has previously expressed interest in NFL ownership, specifically with his former team. “It’s definitely something of interest,” Manning said in an ...

US President Donald Trump watched translated excerpts of an interview given by captivity survivor Eli Sharabi to the "Uvda" program, and invited him and other captivity survivors to the White ...

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Good morning. A bunch of people I know (including me) have gotten sick ...